Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Solpadeine

From Wikipedia, the free encyclopedia
1998 advertisement

Solpadeine is the brand name of a range of analgesic medication containing various amounts of paracetamol, ibuprofen, caffeine and codeine, made by Omega Pharma.[1] The range was previously made by GlaxoSmithKline, which sold its portfolio of over-the-counter drugs to Omega Pharma in 2012.[2]

In the United Kingdom there are four different medicines using the Solpadeine name, with different active ingredients. The range includes:

  • Solpadeine Headache, containing paracetamol with caffeine
  • Solpadeine Plus, a compound analgesic containing paracetamol and codeine (co-codamol), with caffeine
  • Solpadeine Max, a compound analgesic containing paracetamol and codeine (with a higher codeine content than Solpadeine Plus)
  • Solpadeine Migraine, a compound analgesic containing ibuprofen and codeine

In 2016 it was one of the biggest selling branded over-the-counter medications in Great Britain, with sales of £43.1 million.[3]

In Australia it is marketed as Panadeine.[4]

[edit]

References

[edit]
  1. "Omega Pharma - Solpadeine". Omega-pharma.pl. Retrieved 14 September 2013.
  2. Corporate Comms (15 March 2012). "GlaxoSmithKline provides further update on divestment of non-core over-the-counter (OTC) brands". Us.gsk.com. Retrieved 14 September 2013.
  3. "A breakdown of the over-the-counter medicines market in Britain in 2016". Pharmaceutical Journal. 28 April 2017. Retrieved 18 March 2020.
  4. "Panadeine - GlaxoSmithKline New Zealand". Gsk.co.nz. 17 November 2008. Retrieved 14 September 2013.